08:00 , Feb 10, 2014 |  BC Week In Review  |  Company News

Microbix, Novartis infectious news

Microbix said the European Patent Office Tribunal ruled in favor of Microbix in a patent challenge filed by Novartis in 2011 relating to Microbix's Virusmax technology. The tribunal ruled that all patent claims are novel...
08:00 , Jan 4, 2010 |  BioCentury  |  Finance

4Q approvals

4Q approvals...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Clinical News

Agriflu regulatory update

FDA granted accelerated approval of a BLA from Novartis for Agriflu to prevent infection from influenza virus subtypes A and B. The trivalent inactivated influenza virus vaccine will be made available in the U.S. for...